"Biopure corporation hbs case" Essays and Research Papers

Sort By:
Satisfactory Essays
Good Essays
Better Essays
Powerful Essays
Best Essays
Page 3 of 50 - About 500 Essays
  • Satisfactory Essays

    Biopure

    • 1060 Words
    • 5 Pages

    Brief Overview: Biopure has two new products namely Oxyglobin and Hemopure. Oxyglobin is a first of its kind‚ new blood substitute for the veterinary market and has passed all the tests and is ready for consumer use. Hemopure is another such blood substitute for the human market and it will take a minimum of two years to launch the product from now. There is a concern about creating an unrealistic price expectation for Hemopure by marketing Oxyglobin before Hemopure. Whereas another point of view

    Free Blood Blood transfusion

    • 1060 Words
    • 5 Pages
    Satisfactory Essays
  • Powerful Essays

    Biopure Case Summary

    • 1918 Words
    • 8 Pages

    in its ability to market its blood substitute technology for both animal and human use. Further‚ Biopure has the patents and FDA approval to forge ahead in the animal market with a two-to-five year time buffer from new competition (using similar technology). One of the company’s weaknesses is that it has not received FDA approval on Hemopure‚ and there are two other companies that could beat Biopure to the market with similar products. But if the FDA does not approve Hemopure‚ which could have

    Premium Blood Pharmacology Marketing

    • 1918 Words
    • 8 Pages
    Powerful Essays
  • Good Essays

    Biopure Case Summary

    • 847 Words
    • 4 Pages

    oxygen requirements in a broad range of potential medical applications. The main issue that is plaguing Biopure is how the possible launch of Oxyglobin will affect the future launch and pricing strategies of Hemopure‚ which could provide a larger return for their investment. Biopure’s strength lies in their ability to market its blood substitute products for both human and animal use. Biopure has a product that has been approved by the FDA for animal use and has the intellectual property that will

    Premium Blood Marketing Blood transfusion

    • 847 Words
    • 4 Pages
    Good Essays
  • Good Essays

    MAC Development Corporation The McCaffreys are in a sticky situation as they have tied up land for a development project and everything seems to be falling apart. They have deadlines to meet and so many moving pieces that I had to read the Case Study several times to wrap my head around it all. At the start of the Phoenix project‚ there were basically three main puzzle pieces the McCaffreys had to juggle. The first one was the Village of Woodland‚ where the land was located‚ had verbally

    Premium September 11 attacks Investment Risk

    • 1453 Words
    • 6 Pages
    Good Essays
  • Satisfactory Essays

    HBS Case

    • 333 Words
    • 2 Pages

    Case: Land Securities Group (A): Choosing Cost or Fair Value on Adoption of IFRS Case Number: 9-105-014 Topic: Financial Reporting and Control Description: A U.K. real estate firm‚ required to adopt international accounting standards (IAS) by 2005‚ must change the reporting of its primary asset (investment property) from the revaluation model under U.K. GAAP to either the cost or fair-value model under IAS. This would have a number of effects on European investment property firms‚ including

    Premium Financial statements International Financial Reporting Standards Finance

    • 333 Words
    • 2 Pages
    Satisfactory Essays
  • Powerful Essays

    Biopure

    • 3679 Words
    • 15 Pages

    veterinarians and trade fair attracted 2‚000 to 10‚000 veterinarian each. In additional to all the strategies above‚ we recommend BioPure to launch campaign “Love Me Love My Pet” in order to increase awareness to people and encourage them to save pet’s life like our own. For people not to differentiate human life and animal life but rather think of it in the same aspect. BioPure should joint this campaign with non-profit organizer and government in order to emphasize the important of the issue publicly

    Free Blood

    • 3679 Words
    • 15 Pages
    Powerful Essays
  • Satisfactory Essays

    Biopure

    • 386 Words
    • 2 Pages

    Biopure Overview: * Biopure Corporation is a privately owned biopharmaceutical firm specializing in the ultrapurification of proteins for human and veterinary use. * It is one of the three legitimate contenders in the emerging field of “blood substitutes”. * Their products Oxyglobin and Hemopure are blood substitutes for the animal and the human market respectively. * Oxyglobin has just received final FDA approval for commercial release and is ready for launch. Hemopure would soon

    Premium Blood Blood transfusion

    • 386 Words
    • 2 Pages
    Satisfactory Essays
  • Powerful Essays

    Biopure Corp. Case Study

    • 1693 Words
    • 7 Pages

    Biopure Corporation Written Case Study I. Current Situation Audit A. Issue Oxyglobin and Hemopure are two blood substitutes that Biopure Corporation was developing. Oxyglobin was recently approved by the FDA for veterinary use while Hemapure is estimated to be approved in two years for human use. If Oxyglobin is launched it will be the first blood substitute for the veterinary market a small and price sensitive market. There is a perceived risk by Ted Jacobs‚ the VP of Human Clinical Trials

    Free Blood Blood transfusion

    • 1693 Words
    • 7 Pages
    Powerful Essays
  • Good Essays

    Biopure Case Group1 SecB

    • 977 Words
    • 36 Pages

    Biopure  Case  Analysis                     Group  1‚  Section  B     The  analysis  deals  with  the  Target  Markets  and  their  different  segments  for  the  two  products  of   Biopure  Corporation‚  namely  Oxyglobin  and  Hemopure.     Oxyglobin   -­‐ Used  as  a  substitute  for  blood  transfusion  in  dogs.   -­‐ Target   market   is  30%   of   all   the

    Premium

    • 977 Words
    • 36 Pages
    Good Essays
  • Good Essays

    How best to exploit the opportunity presented by Oxyglobin without jeopardizing the potential of Hemopure is a tough problem for Biopure’s executive. According to the financial analysis‚ it is suggested that Biopure begin to sell Oxyglobin at $150 per unit to emergency care practice at the Veterinary Blood Market and have its own distribution network. This will make a profit of $5 million at first year and $17 million thereafter. The steadfast income will consolidate Biopure’s financial structure

    Premium Blood Marketing Economics

    • 616 Words
    • 3 Pages
    Good Essays
Page 1 2 3 4 5 6 7 8 9 50